MAPK3 and central nervous system cancer: The inhibition of 37LRP, a precursor of RPSA, represses glioma growth and invasion, and the resulting downregulation of RPSA suppresses p-ERK1/2 and p-p38 in U251 cells, suggesting the inhibitory effect of RPSA on glioma tumorigenesis [39].